Salvage alloSCT remains option for progressing CML patients
Research demonstrates the continuing role of allogeneic stem cell transplantation as a salvage option for patients with chronic myeloid leukaemia who progress to accelerated phase or blast crisis after tyrosine kinase inhibitor failure.
Source: MedWire News - Category: Consumer Health News Tags: Chronic myeloid leukaemia Source Type: news
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Health | Leukemia | Stem Cell Therapy | Stem Cells | Transplants